Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trial.
about
Pulmonary toxicity among cancer patients treated with a combination of docetaxel and gemcitabine: a meta-analysis of clinical trials.Docetaxel in advanced non-small cell lung cancer.Prognostic significance of functional capacity and exercise behavior in patients with metastatic non-small cell lung cancerDocetaxel in the treatment of advanced non-small-cell lung cancer.
P2860
Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trial.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Combination second-line chemot ...... motherapy: a phase I/II trial.
@ast
Combination second-line chemot ...... motherapy: a phase I/II trial.
@en
type
label
Combination second-line chemot ...... motherapy: a phase I/II trial.
@ast
Combination second-line chemot ...... motherapy: a phase I/II trial.
@en
prefLabel
Combination second-line chemot ...... motherapy: a phase I/II trial.
@ast
Combination second-line chemot ...... motherapy: a phase I/II trial.
@en
P2093
P921
P1476
Combination second-line chemot ...... motherapy: a phase I/II trial.
@en
P2093
Hironobu Ohmatsu
Kaoru Kubota
Koichi Goto
Ryutaro Kakinuma
Seiji Niho
Taketoshi Matsumoto
Yutaka Nishiwaki
P2888
P356
10.1007/S00280-003-0618-8
P577
2003-04-24T00:00:00Z
P6179
1003168262